<DOC>
	<DOCNO>NCT01346410</DOCNO>
	<brief_summary>This study evaluate local control rate well acute late toxicity rate stereotactic body radiotherapy ( SBRT ) treatment unresectable pancreatic cancer .</brief_summary>
	<brief_title>Stereotactic Body Radiotherapy Unresectable Pancreatic Cancer</brief_title>
	<detailed_description>This single institution , non-randomized , prospective , phase IV trial SBRT unresectable pancreatic cancer . Data collect include patient demographic , pathology data , tumor stage , SBRT dose fractionation scheme , dose receive adjacent critical normal tissue , tumor recurrence data , acute late toxicity . Follow data collect patient 's standard office visit . The anticipated duration study 5 year .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patient age &gt; = 18 year Performance status 03 Unresectable pancreatic cancer Maximum tumor diameter &lt; 7.5 cm Signed studyspecific consent form Maximum tumor diameter &gt; 7.5 cm Prior radiotherapy upper abdomen Pregnant lactate woman , due potential exposure fetus RT unknown effect RT lactate female Patients psychiatric addictive disorder would preclude obtain informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>pancreatic cancer</keyword>
</DOC>